Renaissance Capital logo

OCDX News

2021's biggest IPOs are some of the biggest losers

RYAN

In 2021, 27 IPOs raised $1 billion or more, the biggest-ever crop of billion-dollar IPOs in a single year. While the largest issuers have historically outperformed the broader group average, that is not the case for 2021 IPOs. Of last year's 27 billion-dollar deals, just three are trading above issue (11%), and the group averages a -40% return, below the total 2021 average of -33%...read more

Updated: Renaissance Capital's 1Q 2021 US IPO Market Review

CPNG

Explosive IPO Market Delivers the Busiest Quarter Since 2000 The US IPO market produced its busiest quarter in over two decades, with 100 IPOs raising $39.2 billion. Fueled by momentum from 2020, the combination of high volume and large offerings resulted in the biggest first quarter by proceeds ever. Healthcare...read more

US IPO Weekly Recap: January closes out with 3 billion-dollar deals in an 8 IPO week

SHLS

The first month of 2021 closed out with eight IPOs, 24 SPACs, and one postponement. Three issuers raised more than $1 billion, bringing the count of billion-dollar US IPOs in January to six, the most in a single month ever. Just one IPO submitted an initial filing ahead of the February lull, but SPACs kept the pipeline active with 27 new filings. Oaktree-backed ...read more

Ortho Clinical Diagnostics prices IPO below the range at $17

OCDX

Ortho Clinical Diagnostics, a Carlyle-backed global provider of in vitro diagnostic products, raised $1.3 billion by offering 76 million shares at $17, below the range of $20 to $23. The company increased its offering by 6.0 million shares (9%). At pricing, Ortho Clinical raised 14% less in proceeds than anticipated. Ortho Clinical Diagnostics plans to list on the Nasdaq under...read more